Janus Henderson Group plc 13D and 13G filings for Eagle Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 10:25 am Sale | 2024-09-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -775,525 (Position Closed) | Filing |
| 2024-02-13 3:53 pm Sale | 2023-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | JANUS HENDERSON GROUP PLC JHG | 775,525 6.000% | -454,347 (-36.94%) | Filing |
| 2023-02-13 09:26 am Sale | 2022-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | JANUS HENDERSON GROUP PLC JHG | 1,229,872 9.400% | -298,280 (-19.52%) | Filing |
| 2022-02-10 6:01 pm Sale | 2021-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | JANUS HENDERSON GROUP PLC JHG | 1,528,152 11.800% | -165,921 (-9.79%) | Filing |
| 2021-02-11 4:39 pm Sale | 2020-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | JANUS HENDERSON GROUP PLC JHG | 1,694,073 13.000% | -105,636 (-5.87%) | Filing |